Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN

#For patients

Written for adults considering a peptide as part of their health management.

Explainer

Peptides for sexual function

PT-141 has phase 3 evidence and one narrow US approval, but the evidence does not support every libido or erectile-function claim made online.

6 Aug 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Tirzepatide vials: what the label says

Mounjaro and Zepbound use single-dose vials. Pooling drug between vials is not described in either label. Here is what the prescribing information says.

6 Aug 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

When retatrutide feels like it wore off

Day-to-day appetite is not a retatrutide dose meter. Trials used once-weekly dosing and planned escalation, not symptom-led midweek changes.

6 Aug 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

ACTH-fragment nootropics: what we know

Semax, Org 2766 and ACTH(4-10) itself come from one hormone. Here is what the class evidence shows in humans, and where it runs out.

5 Aug 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

Peptides for cognitive performance

No peptide has a controlled human trial showing cognitive enhancement in healthy adults. Here is what the Semax and Cerebrolysin record actually shows.

5 Aug 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

Tirzepatide pregnancy: what the label says

The Mounjaro prescribing label flags insufficient human data and animal fetal harm. Here is what the label, animal studies, and early cohort data say.

5 Aug 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

The first week on ipamorelin and CJC-1295

Two good nights on an ipamorelin and CJC-1295 blend is not a result yet. Here is what the published timelines actually look like.

3 Aug 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

Peptide blood tests before and after

What a before and after blood panel can show around retatrutide, hCG or Semax, what it cannot, and why interpretation belongs with a clinician.

3 Aug 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

Why you cannot tell which peptide did it

Running BPC-157, TB-500 and tirzepatide together makes every result uninterpretable. Here is why pharmacology treats one variable at a time.

3 Aug 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Semax and Selank together: the evidence

Semax and Selank are Russian nootropic peptides with small, mostly Russian-language trial records. No published study has given both to the same person.

3 Aug 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Stacking peptides on top of retatrutide

Readers ask about adding GHK-Cu, ipamorelin and CJC-1295 to retatrutide. No published human trial has tested any of those combinations.

3 Aug 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

What an IGF-1 result actually tells you

IGF-1 is a monitoring marker, not a dial to turn. What the number shows, what tesamorelin is licensed for, and why dose calls belong with a prescriber.

3 Aug 2026 · PeptideMethods Editorial Team · 4 min read